ID   GSH1_HUMAN              Reviewed;         637 AA.
AC   P48506; Q14399;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 159.
DE   RecName: Full=Glutamate--cysteine ligase catalytic subunit;
DE            EC=6.3.2.2;
DE   AltName: Full=GCS heavy chain;
DE   AltName: Full=Gamma-ECS;
DE   AltName: Full=Gamma-glutamylcysteine synthetase;
GN   Name=GCLC; Synonyms=GLCL, GLCLC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1350904; DOI=10.1080/02500169208537777;
RA   Gipp J.J., Chang C., Mulcahy R.T.;
RT   "Cloning and nucleotide sequence of a full-length cDNA for human liver
RT   gamma-glutamylcysteine synthetase.";
RL   Biochem. Biophys. Res. Commun. 185:29-35(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-462.
RG   NIEHS SNPs program;
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Hippocampus, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-27.
RC   TISSUE=Foreskin fibroblast;
RX   PubMed=7726839; DOI=10.1006/bbrc.1995.1493;
RA   Mulcahy R.T., Gipp J.J.;
RT   "Identification of a putative antioxidant response element in the 5'-
RT   flanking region of the human gamma-glutamylcysteine synthetase heavy
RT   subunit gene.";
RL   Biochem. Biophys. Res. Commun. 209:227-233(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 341-440, AND VARIANT HAGGSD
RP   LEU-370.
RX   PubMed=10515893;
RA   Beutler E., Gelbart T., Kondo T., Matsunaga A.T.;
RT   "The molecular basis of a case of gamma-glutamylcysteine synthetase
RT   deficiency.";
RL   Blood 94:2890-2894(1999).
RN   [7]
RP   CHARACTERIZATION.
RX   PubMed=9675072; DOI=10.1006/prep.1998.0897;
RA   Misra I., Griffith O.W.;
RT   "Expression and purification of human gamma-glutamylcysteine
RT   synthetase.";
RL   Protein Expr. Purif. 13:268-276(1998).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-5 AND SER-8, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   VARIANT HAGGSD LEU-158.
RX   PubMed=10733484;
RA   Ristoff E., Augustson C., Geissler J., de Rijk T., Carlsson K.,
RA   Luo J.-L., Andersson K., Weening R.S., van Zwieten R., Larsson A.,
RA   Roos D.;
RT   "A missense mutation in the heavy subunit of gamma-glutamylcysteine
RT   synthetase gene causes hemolytic anemia.";
RL   Blood 95:2193-2196(2000).
RN   [13]
RP   VARIANT HAGGSD CYS-127.
RX   PubMed=12663448; DOI=10.1182/blood-2002-11-3622;
RA   Hamilton D., Wu J.H., Alaoui-Jamali M., Batist G.;
RT   "A novel missense mutation in the gamma-glutamylcysteine synthetase
RT   catalytic subunit gene causes both decreased enzymatic activity and
RT   glutathione production.";
RL   Blood 102:725-730(2003).
CC   -!- CATALYTIC ACTIVITY: ATP + L-glutamate + L-cysteine = ADP +
CC       phosphate + gamma-L-glutamyl-L-cysteine.
CC   -!- ENZYME REGULATION: Feedback inhibition by glutathione.
CC   -!- PATHWAY: Sulfur metabolism; glutathione biosynthesis; glutathione
CC       from L-cysteine and L-glutamate: step 1/2.
CC   -!- SUBUNIT: Heterodimer of a catalytic heavy chain and a regulatory
CC       light chain.
CC   -!- DISEASE: Hemolytic anemia due to gamma-glutamylcysteine synthetase
CC       deficiency (HAGGSD) [MIM:230450]: A disease characterized by
CC       hemolytic anemia, glutathione deficiency, myopathy, late-onset
CC       spinocerebellar degeneration, and peripheral neuropathy.
CC       {ECO:0000269|PubMed:10515893, ECO:0000269|PubMed:10733484,
CC       ECO:0000269|PubMed:12663448}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glutamate--cysteine ligase type 3
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/gclc/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M90656; AAA58499.1; -; mRNA.
DR   EMBL; AY780794; AAV31778.1; -; Genomic_DNA.
DR   EMBL; AL033397; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022487; AAH22487.1; -; mRNA.
DR   EMBL; BC039894; AAH39894.1; -; mRNA.
DR   EMBL; L39773; AAC41751.1; -; Genomic_DNA.
DR   EMBL; AF118846; AAD18031.1; -; Genomic_DNA.
DR   CCDS; CCDS4952.1; -.
DR   PIR; JH0611; JH0611.
DR   RefSeq; NP_001184044.1; NM_001197115.1.
DR   RefSeq; NP_001489.1; NM_001498.3.
DR   UniGene; Hs.654465; -.
DR   ProteinModelPortal; P48506; -.
DR   SMR; P48506; -.
DR   BioGrid; 108991; 10.
DR   IntAct; P48506; 2.
DR   STRING; 9606.ENSP00000229416; -.
DR   BindingDB; P48506; -.
DR   ChEMBL; CHEMBL4055; -.
DR   DrugBank; DB00151; L-Cysteine.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB00163; Vitamin E.
DR   iPTMnet; P48506; -.
DR   PhosphoSitePlus; P48506; -.
DR   BioMuta; GCLC; -.
DR   DMDM; 1346190; -.
DR   EPD; P48506; -.
DR   PaxDb; P48506; -.
DR   PeptideAtlas; P48506; -.
DR   PRIDE; P48506; -.
DR   DNASU; 2729; -.
DR   Ensembl; ENST00000229416; ENSP00000229416; ENSG00000001084.
DR   GeneID; 2729; -.
DR   KEGG; hsa:2729; -.
DR   UCSC; uc003pbx.5; human.
DR   CTD; 2729; -.
DR   DisGeNET; 2729; -.
DR   GeneCards; GCLC; -.
DR   HGNC; HGNC:4311; GCLC.
DR   HPA; CAB009569; -.
DR   HPA; HPA036359; -.
DR   HPA; HPA036360; -.
DR   MalaCards; GCLC; -.
DR   MIM; 230450; phenotype.
DR   MIM; 606857; gene+phenotype.
DR   neXtProt; NX_P48506; -.
DR   OpenTargets; ENSG00000001084; -.
DR   Orphanet; 33574; Gamma-glutamylcysteine synthetase deficiency.
DR   PharmGKB; PA28612; -.
DR   eggNOG; KOG3754; Eukaryota.
DR   eggNOG; ENOG410XQIG; LUCA.
DR   GeneTree; ENSGT00390000011908; -.
DR   HOGENOM; HOG000199354; -.
DR   HOVERGEN; HBG005924; -.
DR   InParanoid; P48506; -.
DR   KO; K11204; -.
DR   OMA; PIQRTTE; -.
DR   OrthoDB; EOG091G03DC; -.
DR   PhylomeDB; P48506; -.
DR   TreeFam; TF105644; -.
DR   BioCyc; MetaCyc:ENSG00000001084-MONOMER; -.
DR   BRENDA; 6.3.2.2; 2681.
DR   Reactome; R-HSA-1614635; Sulfur amino acid metabolism.
DR   Reactome; R-HSA-174403; Glutathione synthesis and recycling.
DR   UniPathway; UPA00142; UER00209.
DR   ChiTaRS; GCLC; human.
DR   GeneWiki; GCLC; -.
DR   GenomeRNAi; 2729; -.
DR   PMAP-CutDB; P48506; -.
DR   PRO; PR:P48506; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000001084; -.
DR   CleanEx; HS_GCLC; -.
DR   ExpressionAtlas; P48506; baseline and differential.
DR   Genevisible; P48506; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0017109; C:glutamate-cysteine ligase complex; IEA:Ensembl.
DR   GO; GO:0043531; F:ADP binding; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0050662; F:coenzyme binding; IPI:UniProtKB.
DR   GO; GO:0016595; F:glutamate binding; IDA:UniProtKB.
DR   GO; GO:0004357; F:glutamate-cysteine ligase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IDA:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0071372; P:cellular response to follicle-stimulating hormone stimulus; IEA:Ensembl.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0097069; P:cellular response to thyroxine stimulus; IEA:Ensembl.
DR   GO; GO:0006534; P:cysteine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006536; P:glutamate metabolic process; IDA:UniProtKB.
DR   GO; GO:0006750; P:glutathione biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0019852; P:L-ascorbic acid metabolic process; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:2001237; P:negative regulation of extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:2000490; P:negative regulation of hepatic stellate cell activation; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0050880; P:regulation of blood vessel size; IMP:UniProtKB.
DR   GO; GO:0051900; P:regulation of mitochondrial depolarization; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0046685; P:response to arsenic-containing substance; IEA:Ensembl.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; IDA:UniProtKB.
DR   GO; GO:0009725; P:response to hormone; IDA:UniProtKB.
DR   GO; GO:0044752; P:response to human chorionic gonadotropin; IEA:Ensembl.
DR   GO; GO:0070555; P:response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0051409; P:response to nitrosative stress; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   GO; GO:0000096; P:sulfur amino acid metabolic process; TAS:Reactome.
DR   InterPro; IPR004308; GCS.
DR   PANTHER; PTHR11164; PTHR11164; 1.
DR   Pfam; PF03074; GCS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Complete proteome; Disease mutation;
KW   Glutathione biosynthesis; Hereditary hemolytic anemia; Ligase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    637       Glutamate--cysteine ligase catalytic
FT                                subunit.
FT                                /FTId=PRO_0000192563.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   VARIANT      55     55       L -> S (in dbSNP:rs2066512).
FT                                /FTId=VAR_014884.
FT   VARIANT     127    127       R -> C (in HAGGSD; dbSNP:rs760031222).
FT                                {ECO:0000269|PubMed:12663448}.
FT                                /FTId=VAR_021110.
FT   VARIANT     158    158       P -> L (in HAGGSD).
FT                                {ECO:0000269|PubMed:10733484}.
FT                                /FTId=VAR_015403.
FT   VARIANT     370    370       H -> L (in HAGGSD; dbSNP:rs121907946).
FT                                {ECO:0000269|PubMed:10515893}.
FT                                /FTId=VAR_013514.
FT   VARIANT     462    462       P -> S (in dbSNP:rs17883718).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_021100.
SQ   SEQUENCE   637 AA;  72766 MW;  511F33F106A15504 CRC64;
     MGLLSQGSPL SWEETKRHAD HVRRHGILQF LHIYHAVKDR HKDVLKWGDE VEYMLVSFDH
     ENKKVRLVLS GEKVLETLQE KGERTNPNHP TLWRPEYGSY MIEGTPGQPY GGTMSEFNTV
     EANMRKRRKE ATSILEENQA LCTITSFPRL GCPGFTLPEV KPNPVEGGAS KSLFFPDEAI
     NKHPRFSTLT RNIRHRRGEK VVINVPIFKD KNTPSPFIET FTEDDEASRA SKPDHIYMDA
     MGFGMGNCCL QVTFQACSIS EARYLYDQLA TICPIVMALS AASPFYRGYV SDIDCRWGVI
     SASVDDRTRE ERGLEPLKNN NYRISKSRYD SIDSYLSKCG EKYNDIDLTI DKEIYEQLLQ
     EGIDHLLAQH VAHLFIRDPL TLFEEKIHLD DANESDHFEN IQSTNWQTMR FKPPPPNSDI
     GWRVEFRPME VQLTDFENSA YVVFVVLLTR VILSYKLDFL IPLSKVDENM KVAQKRDAVL
     QGMFYFRKDI CKGGNAVVDG CGKAQNSTEL AAEEYTLMSI DTIINGKEGV FPGLIPILNS
     YLENMEVDVD TRCSILNYLK LIKKRASGEL MTVARWMREF IANHPDYKQD SVITDEMNYS
     LILKCNQIAN ELCECPELLG SAFRKVKYSG SKTDSSN
//
